Hologic Inc- 详细介绍、公司背景、业务范围、财务数据以及市场表现

关于 Hologic Inc 公司

Hologic, Inc. 是一家医疗技术公司，主要致力于通过早期检测和治疗改善女性的健康和福祉。该公司是诊断产品、医学成像系统和外科产品的开发商、制造商和供应商。其部门包括诊断、乳腺健康、妇科外科和骨骼健康。诊断部门提供一系列诊断产品，主要用于辅助筛查和诊断人类疾病。乳腺健康部门提供广泛的乳腺成像、活检、乳腺手术和病理解决方案组合。妇科外科部门的产品包括 MyoSure 宫腔镜组织切除系统、NovaSure 子宫内膜消融系统、Acessa ProVu 腹腔镜射频消融系统，以及 CoolSeal 血管封闭产品组合和 JustRight 手术缝合器。骨骼健康部门的产品包括 Horizon DXA 和 Fluoroscan Insight FD 迷你 C 臂。

公司简介

公司代码HOLX

公司名称Hologic Inc

上市日期Mar 01, 1990

成立日期1990

CEOMr. Stephen P. (Steve) Macmillan

员工数量7063

证券类型Ordinary Share

年结日Mar 01

公司地址250 Campus Drive

城市MARLBOROUGH

上市交易所NASDAQ Global Select Consolidated

国家United States of America

邮编01752

电话15082632900

网址https://www.hologic.com/

公司代码HOLX

上市日期Mar 01, 1990

成立日期1990

公司高管

名称

名称/职务

职务

持股

持股变动

Mr. Stephen P. (Steve) Macmillan

Chairman of the Board, President, Chief Executive Officer

1.22M

+7.02%

Mr. John M. Griffin

General Counsel

122.84K

+0.07%

Ms. Christiana Stamoulis

Independent Director

47.34K

+4.10%

Mr. Charles J. Dockendorff, CPA

Independent Director

18.81K

+11.00%

Ms. Diana De Walt

Senior Vice President - Human Resources

12.02K

--

Mr. Essex D. Mitchell

Chief Operating Officer

9.93K

-34.65%

Dr. Ludwig N. Hantson, Ph.D.

Independent Director

9.26K

+25.20%

Mr. Mark Horvath

Division President, Breast and Skeletal Health Solutions

7.06K

+15.71%

Mr. Brandon Schnittker

Division President, GYN Surgical Solutions

6.16K

-1.44%

Ms. Nanaz Mohtashami

Independent Director

4.18K

+80.45%

名称

名称/职务

职务

持股

持股变动

Mr. Stephen P. (Steve) Macmillan

Chairman of the Board, President, Chief Executive Officer

1.22M

+7.02%

Mr. John M. Griffin

General Counsel

122.84K

+0.07%

Ms. Christiana Stamoulis

Independent Director

47.34K

+4.10%

Mr. Charles J. Dockendorff, CPA

Independent Director

18.81K

+11.00%

Ms. Diana De Walt

Senior Vice President - Human Resources

12.02K

--

Mr. Essex D. Mitchell

Chief Operating Officer

9.93K

-34.65%

收入明细

单位: USD更新时间: 4月6日周日

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2021

FY2020

FY2019

业务USD

名称

营收

占比

Disposables

663.70M

64.95%

Service

198.60M

19.44%

Capital equipment, components and software

154.20M

15.09%

Other

5.30M

0.52%

地区USD

名称

营收

占比

United States

757.90M

74.17%

Europe

148.90M

14.57%

Asia

59.80M

5.85%

Rest of World

55.20M

5.40%

业务

地区

业务USD

名称

营收

占比

Disposables

663.70M

64.95%

Service

198.60M

19.44%

Capital equipment, components and software

154.20M

15.09%

Other

5.30M

0.52%

股东统计

更新时间: 2月21日周五

持股股东

股东类型

持股股东

股东统计

占比

The Vanguard Group, Inc.

11.94%

T. Rowe Price Investment Management, Inc.

7.99%

BlackRock Institutional Trust Company, N.A.

6.08%

State Street Global Advisors (US)

4.61%

Morgan Stanley Investment Management Ltd. (UK)

3.76%

Other

65.61%

持股股东

股东统计

占比

The Vanguard Group, Inc.

11.94%

T. Rowe Price Investment Management, Inc.

7.99%

BlackRock Institutional Trust Company, N.A.

6.08%

State Street Global Advisors (US)

4.61%

Morgan Stanley Investment Management Ltd. (UK)

3.76%

Other

65.61%

股东类型

股东统计

占比

Investment Advisor

53.38%

Investment Advisor/Hedge Fund

41.11%

Pension Fund

3.07%

Hedge Fund

2.62%

Research Firm

2.19%

Bank and Trust

1.72%

Sovereign Wealth Fund

0.90%

Individual Investor

0.85%

Family Office

0.05%

机构持股

更新时间: 1月20日周一

报告期

机构数

持股数

持股占比

持股变动

2025Q1

1568

238.16M

106.14%

-10.52M

2024Q4

1617

238.36M

106.18%

-10.05M

2024Q3

1583

240.17M

103.42%

-3.00M

2024Q2

1580

234.77M

100.61%

-6.88M

2024Q1

1595

233.34M

99.37%

-7.61M

2023Q4

1584

235.52M

98.14%

-14.13M

2023Q3

1574

242.15M

98.88%

-13.93M

2023Q2

1583

245.52M

99.77%

-12.39M

2023Q1

1582

247.98M

100.57%

-12.56M

2022Q4

1556

249.37M

101.43%

-12.38M

股东持股明细

名称

持股数

占比

持股变动

变动比例

公告日期

The Vanguard Group, Inc.

26.79M

11.94%

-54.38K

-0.20%

Dec 31, 2024

T. Rowe Price Investment Management, Inc.

17.94M

7.99%

-4.20M

-18.97%

Dec 31, 2024

BlackRock Institutional Trust Company, N.A.

13.65M

6.08%

-23.32K

-0.17%

Dec 31, 2024

State Street Global Advisors (US)

10.35M

4.61%

-60.64K

-0.58%

Dec 31, 2024

Morgan Stanley Investment Management Ltd. (UK)

8.44M

3.76%

-455.77K

-5.12%

Dec 31, 2024

Geode Capital Management, L.L.C.

5.73M

2.55%

+144.84K

+2.59%

Dec 31, 2024

Fidelity Management & Research Company LLC

5.15M

2.29%

+82.81K

+1.64%

Dec 31, 2024

Victory Capital Management Inc.

4.92M

2.19%

+24.36K

+0.50%

Dec 31, 2024

Mitsubishi UFJ Asset Management Co., Ltd.

4.40M

1.96%

+129.03K

+3.02%

Dec 31, 2024

Pacer Advisors, Inc.

3.66M

1.63%

+3.57M

+3.88K%

Dec 31, 2024

持股ETF

更新时间: 4月6日周日

机构名称

占比

First Trust Nasdaq Lux Digi Health Solutions ETF

2.99%

LeaderShares AlphaFactor Tactical Focused ETF

2.84%

VictoryShares THB Mid Cap ESG ETF

2.6%

Formidable ETF

2.13%

Global X US Cash Flow Kings 100 ETF

2.11%

First Trust Capital Strength ETF

1.76%

SPDR S&P Health Care Equipment ETF

1.54%

iShares U.S. Medical Devices ETF

1.53%

First Trust Health Care Alphadex Fund

1.52%

John Hancock Fundamental All Cap Core ETF

1.52%

First Trust Nasdaq Lux Digi Health Solutions ETF

占比2.99%

LeaderShares AlphaFactor Tactical Focused ETF

占比2.84%

VictoryShares THB Mid Cap ESG ETF

占比2.6%

Formidable ETF

占比2.13%

Global X US Cash Flow Kings 100 ETF

占比2.11%

First Trust Capital Strength ETF

占比1.76%

SPDR S&P Health Care Equipment ETF

占比1.54%

iShares U.S. Medical Devices ETF

占比1.53%

First Trust Health Care Alphadex Fund

占比1.52%

John Hancock Fundamental All Cap Core ETF

占比1.52%

分红派息

近5年累计派现 0.00 美元

公告日期

分红计划

股权登记日

现金发放日

除权除息日

暂无数据

拆合股

公告日期

类型

比率

暂无数据

公告日期

类型

比率

暂无数据

Hologic Inc

58.360USD

Hologic Inc

58.360

概览

公司